Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 5/2015

01-10-2015

IL-10 and IL-17F Promoter Single Nucleotide Polymorphism and Asthma: A Case-Control Study in South India

Authors: Sareh Raeiszadeh Jahromi, P. A. Mahesh, B. S. Jayaraj, Amrutha D. Holla, Sangeetha Vishweswaraiah, Nallur. B. Ramachandra

Published in: Lung | Issue 5/2015

Login to get access

Abstract

Background

Several studies have assessed the association between IL-17F and IL-10 promoter polymorphisms and asthma, but the results were conflicting. Furthermore, few studies have evaluated the association of cytokine polymorphisms with asthma and its clinical phenotypes.

Objective

This study was conducted to evaluate the association of IL-10 (interleukin 10) and IL-17F (interleukin 17F) promoter polymorphisms (rs1800871, rs1800896 and rs1889570) with asthma and its clinical phenotypes including severity, atopic status, spirometric parameters, and response to treatment in south Indian population. A sub-study was conducted to assess cytokine levels in subjects with different gene variants.

Methods

IL-10 and IL-17F polymorphisms were genotyped in 419 asthmatic patients and 393 controls using Mass ARRAY.

Results

Our results showed an association between IL-10 SNPs and mild asthma. No association was found with any of three SNPs in moderate to severe asthma. Comparison of genotype distribution of IL-17F rs1887570 AA variant among atopic and non-atopic patients showed significant difference (p = 0.024). Correlation analysis of IL-10 and IL-17F SNPs to clinical variables showed a positive correlation between IL-17F rs1887570 AA and number of allergen sensitized (rs = 0.142, p = 0.004). Significant improvement in lung function was observed after 2 months of ICS (Inhaled corticosteroids) and LABA (long acting β2 agonist) treatment in all subjects with no statistically significant difference among SNPs variants. Cytokines levels were similar in different SNP variants.

Conclusion

We observed an association between IL-10 rs1800871 and rs1800896 SNPs and mild asthma, as well as IL-17F rs1887570 AA variant and number of allergens sensitized.
Appendix
Available only for authorised users
Literature
1.
To T, Stanojevic S, Moores G et al (2012) Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 12:204PubMedCentralCrossRefPubMed
2.
3.
4.
Ober C, Hoffjan S (2006) Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 7:95–100CrossRefPubMed
5.
Kim JM, Brannan CI, Copeland NG et al (1992) Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148:3618–3623PubMed
6.
de Waal Malefyt R, Haanen J, Spits H et al (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915–924CrossRef
7.
Akdis M, Burgler S, Crameri R et al (2011) Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127:701–721CrossRefPubMed
8.
Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S (1996) Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 97:1288–1296CrossRefPubMed
9.
Stämpfli MR, Cwiartka M, Gajewska BU et al (1999) Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am J Respir Cell Mol Biol 21:586–596CrossRefPubMed
10.
Haagerup A, Bjerke T, Schiøtz PO et al (2002) Asthma and atopy—a total genome scan for susceptibility genes. Allergy 57:680–686CrossRefPubMed
11.
Wjst M, Fischer G, Immervoll T et al (1999) A genomewide search for linkage to asthma. Ger Asthma Genet Group Genom 58:1–8
12.
Starnes T, Robertson MJ, Sledge G et al (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167:4137–4140CrossRefPubMed
13.
Kawaguchi M, Onuchic LF, Li XD et al (2001) Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 167:4430–4435CrossRefPubMed
14.
Al-Ramli W, Préfontaine D, Chouiali F et al (2009) T (H)17-associated cytokines (IL-17A and IL-17F)in severe asthma. J Allergy Clin Immunol 123:1185–1187CrossRefPubMed
15.
Turner DM, Williams DM, Sankaran D et al (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1–8CrossRefPubMed
16.
Nie W, Fang Z, Li B, Xiu QY (2012) Interleukin-10 promoter polymorphisms and asthma risk: a meta-analysis. Cytokine 60:849–855CrossRefPubMed
17.
Hyun MH, Lee CH, Kang MH et al (2013) Interleukin-10 promoter gene polymorphisms and susceptibility to asthma: a meta-analysis. PLoS One 8:e53758
18.
Chatterjee R, Batra J, Kumar A et al (2005) Interleukin-10 promoter polymorphisms and atopic asthma in North Indians. Clin Exp Allergy 35:914–919CrossRefPubMed
19.
Ramsey CD, Lazarus R, Camargo CA Jr et al (2005) Polymorphisms in the interleukin 17F gene (IL17F) and asthma. Genes Immun 6:236–241CrossRefPubMed
20.
Kawaguchi M, Takahashi D, Hizawa N et al (2006) IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 117:795–801CrossRefPubMed
21.
Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338CrossRefPubMed
22.
Bateman ED, Hurd SS, Barnes PJ et al (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31:143–178CrossRefPubMed
23.
Raeiszadeh Jahromi S, Mahesh PA, Jayaraj BS et al (2014) Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case-control study. J Asthma  18:1–10
24.
Antunes J, Borrego L, Romeira A et al (2009) Skin prick tests and allergy diagnosis. Allergol Immunopathol (Madr) 37:155–164CrossRef
25.
Aas K, Belin L (1973) Standardization of diagnostic work in allergy. Int Arch Allergy Appl Immunol 45:57–60CrossRefPubMed
26.
27.
28.
Li Y, Wang J, Jiang F et al (2012) Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study. BMC Med Genet 13:1PubMedCentralCrossRefPubMed
29.
Barrett JC, Fry B, Maller J et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed
30.
31.
Townley RG, Bewtra A, Wilson AF et al (1986) Segregation analysis of bronchial response to methacholine inhalation challenge in families with and without asthma. J Allergy Clin Immunol 77:101–107CrossRefPubMed
32.
Lyon H, Lange C, Lake S et al (2004) IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol 26:155–165
33.
Hussein YM, Shalaby SM, Mohamed RH et al (2011) Association between genes encoding components of the IL-10/IL-0 receptor pathway and asthma in children. Ann Allergy Asthma Immunol 106:474–480CrossRefPubMed
34.
Movahedi M, Mahdaviani SA, Rezaei N et al (2008) IL-10, TGF-beta, IL-2, IL-12, and IFN-gamma cytokine gene polymorphisms in asthma. J Asthma 45:790–794CrossRefPubMed
35.
Kim KW, Lee KE, Hong JY et al (2011) Involvement of IL-10 gene promoter polymorphisms in the susceptibility for childhood asthma. Lung 189:417–423CrossRefPubMed
36.
Zedan M, Settin A, Farag MK et al (2008) Gene polymorphisms of tumor necrosis factor alpha-308 and interleukin-10-1082 among asthmatic Egyptian children. Allergy Asthma Proc 29:268–273CrossRefPubMed
37.
Park BL, Kim LH, Choi YH et al (2004) Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy. J Hum Genet 49:517–527CrossRefPubMed
38.
Sagar S, Verheijden KA, Georgiou NA et al (2013) Differential regulation of inflammation and immunity in mild and severe experimental asthma. Mediators Inflamm 2013:808470PubMedCentralCrossRefPubMed
39.
Mörmann M, Rieth H, Hua TD et al (2004) Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun 5:246–255CrossRefPubMed
40.
de Waal Malefyt R, Yssel H, Roncarolo MG et al (1992) Interleukin-10. Curr Opin Immunol 4:314–320CrossRef
41.
Suarez A, Castro P, Alonso R et al (2003) Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75:711–717CrossRefPubMed
42.
Karjalainen J, Hulkkonen J, Nieminen MM et al (2003) Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy 33:78–83CrossRefPubMed
43.
44.
Fujita J, Kawaguchi M, Kokubu F et al (2012) Interleukin-33 induces interleukin-17F in bronchial epithelial cells. Allergy 67:744–750
45.
Tantisira KG, Lasky-Su J, Harada M et al (2011) Genomewide association between GLCCI1 and response to glucocorticoid therapy inasthma. N Engl J Med 365:1173–1183PubMedCentralCrossRefPubMed
Metadata
Title
IL-10 and IL-17F Promoter Single Nucleotide Polymorphism and Asthma: A Case-Control Study in South India
Authors
Sareh Raeiszadeh Jahromi
P. A. Mahesh
B. S. Jayaraj
Amrutha D. Holla
Sangeetha Vishweswaraiah
Nallur. B. Ramachandra
Publication date
01-10-2015
Publisher
Springer US
Published in
Lung / Issue 5/2015
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-015-9753-3

Other articles of this Issue 5/2015

Lung 5/2015 Go to the issue

OriginalPaper

A Clinical Classification Scheme for Tracheobronchomegaly (Mounier-Kuhn Syndrome)

OriginalPaper

Inflammatory Cytokines Contribute to Asbestos-Induced Injury of Mesothelial Cells

Letter

Comments Concerning “Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis”

OriginalPaper

Neutrophil CD64 Expression as a Diagnostic Marker in Patients Hospitalized with Exacerbations of COPD: A Prospective Observational Study

Report

A Novel Method for In Vivo Imaging of Solitary Lung Nodules Using Navigational Bronchoscopy and Confocal Laser Microendoscopy

OriginalPaper

Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 Studies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits